Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for secondary packaging, primary packaging labeling, batch testing/quality control and batch release)

The drug is used to treat patients with chronic myeloid leukemia (in chronic or progressive stage), as well as for the treatment of essential thrombocythemia or polycythemia with a high risk of thromboembolic complications.

Dosage form: capsules

ATC: L01XX05